featured
Tirbanibulin 1% for Anogenital Warts
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tirbanibulin 1% ointment as a potential novel treatment for anogenital warts
J Eur Acad Dermatol Venereol 2022 Jan 23;[EPub Ahead of Print], S Braasch, PA Gerber, SA BraunFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.